Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-03-07
2006-03-07
Stucker, Jeffrey (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C424S185100, C424S188100, C424S208100, C530S324000, C530S325000, C530S326000, C530S327000, C530S328000, C530S329000
Reexamination Certificate
active
07009037
ABSTRACT:
The present invention comprises novel and modified peptides capable of inducing a HIV-1 specific immune response without antagonizing the cytotoxic T-cell activity in order to achieve an effective prophylactic and therapeutic vaccine against HIV. The peptides are based on conserved regions of HIV gag p17 and p24 proteins. Antigens in free- or carrier-bound form comprising at least one of the said peptides, vaccine compositions containing at least one of the antigens, immunoassay kits and a method of detecting antibodies induced by HIV or HIV specific peptides using such antigens, are described.
REFERENCES:
patent: 5972339 (1999-10-01), Walker
patent: 0732339 (1996-09-01), None
patent: 2236754 (1991-04-01), None
patent: 9837089 (1989-08-01), None
patent: 91/13360 (1991-09-01), None
patent: 98/29551 (1998-07-01), None
patent: 9958658 (1999-11-01), None
Ruan et al. “The Drosophila Insulin Receptor Contains a Novel Carboxyl-terminal Extension Likely to Play an Important Role in Signal Transduction” Journal of Biological Chemistry, vol. 270, No. 9(Mar. 3, 1995), pp. 4236-4243.
Riffkin et al. AA single amino-acid change between the antigenically different extracellular serine proteases V2 and B2 from Dichelobacter nodosus@, Gene, vol. 167 (1995), pp. 279-283.
Abaza et al. AEffects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization@, Journal of Protein Chemistry, vol. 11, No. 5 (1992), pp 433-444.
Cruse et al. Illustrated Dictionary of Immunology (Boca Raton, FL, CRC Press, Inc., 1995), p. 309.
Paul, Fundamental Immunology, (Philadelphia & New York, Lippincott-Raven Publishers, 1993), pp. 250 and 1311-1312.
Cohen et al. APronounced acute immunosuppression in vivo mediated by HIV Tat challenge@, Proceedings of the National Academy of Sciences of the United States of America, vol. 96, Issue 19(Sep. 14, 1999), pp. 10842□10847.
Truong et al., J. Medical Virology, 51, 1997, pp. 145-151.
Chong et al., Int. J. Peptide Protein Res., 41, 1992, pp. 21-27.
Bionor Immuno AS
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Modified HIV-1gag p17 peptide and immunogenic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified HIV-1gag p17 peptide and immunogenic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified HIV-1gag p17 peptide and immunogenic composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3602011